Baseline characteristics of the North American prodromal Synucleinopathy cohort
暂无分享,去创建一个
Daniel E. Huddleston | Jonathan E. Elliott | B. Boeve | R. Postuma | D. Huddleston | A. Videnovic | A. Pelletier | A. Avidan | D. Bliwise | C. Schenck | S. Criswell | E. S. St. Louis | J. Fields | E. During | L. Forsberg | Yo-El S Ju | M. Miglis | Susan R. Criswell | Jennifer S Mcleland | Susan R Criswell | Michael J Howell | D. Shprecher | M. Lim | J. Lee-Iannotti | J. Gagnon | A. Keil | Jennifer McLeland | Allison T. Keil
[1] C. Adler,et al. Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder , 2021, The Lancet Neurology.
[2] J. Volkmann,et al. Consistent skin α-synuclein positivity in REM sleep behavior disorder - A two center two-to-four-year follow-up study. , 2021, Parkinsonism & related disorders.
[3] C. Chan,et al. Montreal Cognitive Assessment — Single Cutoff Achieves Screening Purpose , 2020, Neuropsychiatric disease and treatment.
[4] D. Kunz,et al. Clinical trials in REM sleep behavioural disorder: challenges and opportunities , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.
[5] Jonathan E. Elliott,et al. Post-traumatic stress disorder increases odds of REM sleep behavior disorder and other parasomnias in Veterans with and without comorbid traumatic brain injury. , 2020, Sleep.
[6] Yves Dauvilliers,et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study , 2019, Brain : a journal of neurology.
[7] Laura Verga,et al. The risk of neurodegeneration in REM sleep behavior disorder: A systematic review and meta-analysis of longitudinal studies. , 2019, Sleep medicine reviews.
[8] Charles Mock,et al. Version 3 of the National Alzheimer’s Coordinating Center’s Uniform Data Set , 2018, Alzheimer disease and associated disorders.
[9] Yves Dauvilliers,et al. REM sleep behaviour disorder , 2018, Nature Reviews Disease Primers.
[10] G. Mancia,et al. Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS) , 2018, Clinical Autonomic Research.
[11] J. Volkmann,et al. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson’s disease , 2017, Acta Neuropathologica.
[12] E. Tolosa,et al. Assessment of α-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study , 2016, The Lancet Neurology.
[13] E. Mori,et al. The Pareidolia Test: A Simple Neuropsychological Test Measuring Visual Hallucination-Like Illusions , 2016, PloS one.
[14] Tracy K. Witte,et al. The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and Initial Psychometric Evaluation. , 2015, Journal of traumatic stress.
[15] E. Tolosa,et al. Enteric nervous system α-synuclein immunoreactivity in idiopathic REM sleep behavior disorder , 2015, Neurology.
[16] G. Deuschl,et al. MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[17] B. Boeve,et al. Antidepressants Increase REM Sleep Muscle Tone in Patients with and without REM Sleep Behavior Disorder. , 2015, Sleep.
[18] W. Oertel,et al. Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: A multicenter study , 2015, Annals of neurology.
[19] Dong Zhou,et al. Gender differences in REM sleep behavior disorder: a clinical and polysomnographic study in China. , 2015, Sleep medicine.
[20] J. Molinuevo,et al. Five‐year follow‐up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder , 2014, Movement disorders : official journal of the Movement Disorder Society.
[21] R. Rosenberg,et al. The American Academy of Sleep Medicine Inter-scorer Reliability program: respiratory events. , 2014, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.
[22] R. Postuma,et al. Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal? , 2013, Sleep.
[23] C Trenkwalder,et al. Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group. , 2013, Sleep medicine.
[24] Jacques Montplaisir,et al. Rapid eye movement sleep behavior disorder as a biomarker for neurodegeneration: the past 10 years. , 2013, Sleep medicine.
[25] Carlos H Schenck,et al. Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. , 2013, Sleep medicine.
[26] C. Adler,et al. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. , 2013, Sleep medicine.
[27] T. Dall,et al. The current and projected economic burden of Parkinson's disease in the United States , 2013, Movement disorders : official journal of the Movement Disorder Society.
[28] Poul Jennum,et al. A single‐question screen for rapid eye movement sleep behavior disorder: A multicenter validation study , 2012, Movement disorders : official journal of the Movement Disorder Society.
[29] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[30] Jens Jordan,et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome , 2011, Clinical Autonomic Research.
[31] L. Larson-Prior,et al. Changing demographics in REM sleep behavior disorder: possible effect of autoimmunity and antidepressants. , 2011, Sleep medicine.
[32] B. Mollenhauer,et al. Intraindividual variability of REM sleep behavior disorder in Parkinson's disease: a comparative assessment using a new REM sleep behavior disorder severity scale (RBDSS) for clinical routine. , 2011, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.
[33] R. Postuma,et al. Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations , 2010, Movement disorders : official journal of the Movement Disorder Society.
[34] R. Uitti,et al. Rasagiline, Parkinson neuroprotection, and delayed-start trials , 2010, Neurology.
[35] P Sandroni,et al. Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.
[36] Tetsuya Takahashi,et al. Opposite effects of SSRIs and tandospirone in the treatment of REM sleep behavior disorder. , 2008, Sleep medicine.
[37] O. Foster,et al. Is REM sleep Behaviour Disorder (RBD) a risk factor of dementia in idiopathic Parkinson's disease? , 2008, Journal of Neurology.
[38] J. Jankovic,et al. Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan , 2007, Movement disorders : official journal of the Movement Disorder Society.
[39] Julien Doyon,et al. Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases , 2006, The Lancet Neurology.
[40] E. Sinforiani,et al. REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson's disease , 2006, Movement Disorders.
[41] Johan Marinus,et al. Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA‐AUT , 2004, Movement disorders : official journal of the Movement Disorder Society.
[42] R. Petersen. Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.
[43] R. Chervin. Epworth sleepiness scale? , 2003, Sleep medicine.
[44] A Sahraie,et al. New Farnsworth-Munsell 100 hue test norms of normal observers for each year of age 5–22 and for age decades 30–70 , 2002, The British journal of ophthalmology.
[45] M. Badr,et al. Effect of gender on the development of hypocapnic apnea/hypopnea during NREM sleep. , 2000, Journal of applied physiology.
[46] J. Cummings,et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. , 2000, The Journal of neuropsychiatry and clinical neurosciences.
[47] M W Mahowald,et al. A parasomnia overlap disorder involving sleepwalking, sleep terrors, and REM sleep behavior disorder in 33 polysomnographically confirmed cases. , 1997, Sleep.
[48] R. Doty,et al. A study of the test-retest reliability of ten olfactory tests. , 1995, Chemical senses.
[49] M. Mahowald,et al. Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder. , 1992, Sleep.
[50] M. Johns,et al. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. , 1991, Sleep.
[51] Diane Podsiadlo,et al. The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons , 1991, Journal of the American Geriatrics Society.
[52] M W Mahowald,et al. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. , 1986, Sleep.
[53] P. Lavie,et al. Severe hypermotility during sleep in treatment of cataplexy with clomipramine. , 1979, Israel journal of medical sciences.
[54] J. Tiffin,et al. The Purdue pegboard; norms and studies of reliability and validity. , 1948, The Journal of applied psychology.
[55] Dean Farnsworth,et al. The Farnsworth-Munsell 100-Hue and Dichotomous Tests for Color Vision* , 1943 .
[56] Ambra Stefani,et al. Idiopathic REM sleep behaviour disorder and neurodegeneration — an update , 2018, Nature Reviews Neurology.
[57] A. Chesson,et al. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology, and Techinical Specifications , 2007 .
[58] Johan Marinus,et al. A short psychosocial questionnaire for patients with Parkinson's disease: the SCOPA-PS. , 2003, Journal of clinical epidemiology.